Aarti Drugs Ltd (BOM:524348)
₹ 471.1 47.15 (11.12%) Market Cap: 43.00 Bil Enterprise Value: 48.61 Bil PE Ratio: 28.41 PB Ratio: 3.37 GF Score: 89/100

Q2 2022 Aarti Drugs Ltd Earnings Call Transcript

Oct 28, 2021 / 09:30AM GMT
Release Date Price: ₹591.95 (-4.88%)
Operator

Ladies and gentlemen, good day and welcome to Aarti Drugs Limited, Q2 FY22 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on the date of this call.

These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Adhish Patil, CFO, Aarti Drugs Limited. Thank you and over to you, sir.

Adhish Patil
Aarti Drugs Limited - CFO

Thank you. Good afternoon everyone, and season's greetings to all of you present on the call to discuss our financial results for Q2 and H1 FY22. Aarti Drugs delivered a resilient performance despite continuous input cost pressures.

Before I take you through the performance highlight, let me remind you that as communicated in the earlier earnings call, the financial performance on a year-on-year basis is not exactly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot